News
Public · Published
Wells Fargo maintains Alkermes at Overweight, raises price target to $68 from $65
Wells Fargo maintained its Overweight rating on Alkermes and raised its price target to $68 from $65, a 4.6% increase. The new target implies 48.8% upside from Alkermes' November 3 closing price of $45.69.
Published:
Updated:
What happened
Wells Fargo maintained its Overweight rating on Alkermes and raised its price target to $68 from $65, a 4.6% increase. The new target implies 48.8% upside from Alkermes’ November 3 closing price of $45.69.
Confirmed
Global impact / market context
The higher target signals that Wells Fargo sees more potential value in Alkermes shares than before, while keeping its positive rating unchanged. If investors act on that view, demand for the shares could rise, but the target is an analyst estimate, not a promised return.
Analyst inference
The article reports one brokerage’s revised target and rating, not a change in Alkermes’ business results or a company announcement. Its stated upside compares the target with the November 3 closing price; it does not establish what the shares will do next.
Confirmed
What to watch
- Check whether Wells Fargo publishes further changes to its rating or target, since either would show whether its view of Alkermes’ expected share value has shifted again. Analyst inference
- Compare future company updates with the assumptions behind the $68 target; the article does not state what business outlook or valuation method supports that estimate. Analyst inference
- Track Alkermes’ share price against the November 3 close of $45.69, the reference point used in the article’s calculation of implied upside. Confirmed
Evidence
- Original source link unavailable